Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound
Telehealth firms Teladoc Health and LifeMD said on Thursday they have signed an agreement with Eli Lilly's direct-to-consumer ...
BioSpace3h
Novo Enters the Ring in Legal Fight Against GLP-1 Compounders
Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...
Medical Marketing & Media3h
Novo Nordisk unveils DTC pharmacy NovoCare, offers discounted Wegovy
The home shipments — which will be fulfilled by CenterWell Pharmacy — include Wegovy injections of 0.25 mg, 0.5 mg, 1 mg, 1.7 ...
Hims & Hers down as judge denies motion over end to Lilly’s Zepbound shortage
Hims & Hers (NYSE:HIMS) fell ~8% in the premarket Thursday after a federal judge denied a motion filed by a compounding trade ...
Novo takes ‘direct shot’ at Hims & Hers with NovoCare , says Citi
Citi analyst Daniel Grosslight keeps a Sell rating on Hims & Hers (HIMS) with a $27 price target after Novo Nordisk (NVO) announced ...
Where Will Eli Lilly Be in 5 Years?
It's hard to argue with the kinds of results Eli Lilly ( LLY 1.71%) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...
BioSpace6d
Lilly Hops On Hot Molecular Glue Train With $1.2B+ Magnet Deal
The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and ...
Novo Nordisk Faces a Perfect Storm: Tariff Shock and Legal Battle Threaten Its Blockbuster Drugs
A looming trade war and a high-stakes lawsuit could shake up the future of Ozempic and Wegovy--here's what's at stake.